LIOVEL Combination Tablets LD (リオベル配合錠LD) Japonska - angleščina - すりの適正使用協議会 RAD-AR Council, Japan

liovel combination tablets ld (リオベル配合錠ld)

teijin pharma limited - alogliptin benzoate; pioglitazone hydrochloride - faint yellow tablet, diameter: 8.7 mm, thickness: 5.0 mm

OSENI FILM COATED TABLET 12.5MG 30MG Singapur - angleščina - HSA (Health Sciences Authority)

oseni film coated tablet 12.5mg 30mg

takeda pharmaceuticals (asia pacific) pte. ltd. - alogliptin benzoate; pioglitazone hcl - tablet, film coated - alogliptin benzoate 12.5 mg; pioglitazone hcl 30 mg

OSENI FILM COATED TABLET 25MG 15MG Singapur - angleščina - HSA (Health Sciences Authority)

oseni film coated tablet 25mg 15mg

takeda pharmaceuticals (asia pacific) pte. ltd. - alogliptin benzoate; pioglitazone hcl - tablet, film coated - alogliptin benzoate 25 mg; pioglitazone hcl 15 mg

OSENI FILM COATED TABLET 25MG 30MG Singapur - angleščina - HSA (Health Sciences Authority)

oseni film coated tablet 25mg 30mg

takeda pharmaceuticals (asia pacific) pte. ltd. - alogliptin benzoate; pioglitazone hcl - tablet, film coated - alogliptin benzoate 25 mg; pioglitazone hcl 30 mg

VIPDOMET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

vipdomet 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack

takeda pharmaceuticals australia pty ltd - metformin hydrochloride, quantity: 1000 mg; alogliptin benzoate, quantity: 17 mg (equivalent: alogliptin, qty 12.5 mg) - tablet, film coated - excipient ingredients: mannitol; purified talc; iron oxide yellow; povidone; microcrystalline cellulose; magnesium stearate; titanium dioxide; crospovidone; hypromellose - vipdomet is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and metformin is appropriate,,- when treatment with metformin alone does not provide adequate control; or - in combination with a thiazolidinedione or with insulin, when dual therapy does not provide adequate control.,vipdomet can also be used to replace separate tablets of alogliptin and metformin in patients already being treated with this combination.

VIPDOMET 12.5/500; 12.5 mg alogliptin (as benzoate) / 500 mg metformin hydrochloride film-coated tablets blister pack Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

vipdomet 12.5/500; 12.5 mg alogliptin (as benzoate) / 500 mg metformin hydrochloride film-coated tablets blister pack

takeda pharmaceuticals australia pty ltd - metformin hydrochloride, quantity: 500 mg; alogliptin benzoate, quantity: 17 mg (equivalent: alogliptin, qty 12.5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; mannitol; magnesium stearate; titanium dioxide; hypromellose; crospovidone; povidone; purified talc; iron oxide yellow - vipdomet is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and metformin is appropriate,,- when treatment with metformin alone does not provide adequate control; or - in combination with a thiazolidinedione or with insulin, when dual therapy does not provide adequate control.,vipdomet can also be used to replace separate tablets of alogliptin and metformin in patients already being treated with this combination.

VIPDOMET 12.5/850; 12.5 mg alogliptin (as benzoate) / 850 mg metformin hydrochloride film-coated tablets blister pack Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

vipdomet 12.5/850; 12.5 mg alogliptin (as benzoate) / 850 mg metformin hydrochloride film-coated tablets blister pack

takeda pharmaceuticals australia pty ltd - metformin hydrochloride, quantity: 850 mg; alogliptin benzoate, quantity: 17 mg (equivalent: alogliptin, qty 12.5 mg) - tablet, film coated - excipient ingredients: titanium dioxide; crospovidone; povidone; microcrystalline cellulose; mannitol; purified talc; magnesium stearate; iron oxide yellow; hypromellose - vipdomet is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and metformin is appropriate,,- when treatment with metformin alone does not provide adequate control; or - in combination with a thiazolidinedione or with insulin, when dual therapy does not provide adequate control.,vipdomet can also be used to replace separate tablets of alogliptin and metformin in patients already being treated with this combination.

Vipdomet 12.5mg1000mg tablets Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

vipdomet 12.5mg1000mg tablets

takeda uk ltd - metformin hydrochloride; alogliptin benzoate - tablet - 1gram ; 12.5mg

Nesina Met 12.5mg/500mg Film-Coated Tablet Malezija - angleščina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nesina met 12.5mg/500mg film-coated tablet

takeda malaysia sdn bhd - metformin hydrochloride; alogliptin benzoate -

KAZANO TABLET Kanada - angleščina - Health Canada

kazano tablet

takeda canada inc - alogliptin (alogliptin benzoate); metformin hydrochloride - tablet - 12.5mg; 500mg - alogliptin (alogliptin benzoate) 12.5mg; metformin hydrochloride 500mg - biguanides